Top Stories

Covishield Dose Gap Reduced To 8-16 Weeks From 12-16

The recommendation for Covishield has not yet been implemented in the national Covid vaccination program

New Delhi:

Indian apex body on NTAGI vaccine recommends administering second dose of COVID-19 Covishield vaccine within 8 to 16 weeks after first dose, official sources close to PTI said on Sunday, second dose of Covishield given within 12-16 weeks after the first dose under the National COVID-19 Vaccination Program.

The National Institute of Immunology (NTAGI) has not yet made any changes in the formulation of Bharat Biotech’s Covaxin, which the second dose is administered 28 days after the first dose. The recommendation for Covishield has not yet been implemented in the national COVID-19 vaccine program.

“NTAGI’s new strategy is based on recent global scientific evidence from system data,” said an official source.

“According to him, when the second dose of Covishield was given eight weeks earlier, the initial antibody response was almost identical when administered between 12 and 16 weeks,” the source explained.

The decision will lead to the speed control of Covishield’s second dose to the remaining six to seven crore people among cases arising in several countries, the source said.

The government on May 13, 2021 caused a gap between the first and second doses of Covichield vaccine from 6-8 weeks to 12-16 weeks depending on the recommendations by NTAGI.

NTAGI provides guidance and advice to the Union Ministry of Health on immunization services for the effective management of immunosuppressive diseases in the country.

(Except for the title, this story has not been edited by the NDTV staff and is published from an integrated feed.)


Source link

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button